دورية أكاديمية
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.
| العنوان: | Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome. |
|---|---|
| المؤلفون: | Corona-Meraz FI; Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 45425, Jalisco, Mexico.; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Vázquez-Del Mercado M; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.; Rheumatology Service, Internal Medicine Division, Civil Hospital of Guadalajara 'Dr. Juan I. Menchaca', Guadalajara 44340, Jalisco, Mexico.; Academic Group UDG-CA-703, 'Immunology and Rheumatology', University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Sandoval-García F; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.; Academic Group UDG-CA-703, 'Immunology and Rheumatology', University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Robles-De Anda JA; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Tovar-Cuevas AJ; Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 45425, Jalisco, Mexico., Rosales-Gómez RC; Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 45425, Jalisco, Mexico., Guzmán-Ornelas MO; Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 45425, Jalisco, Mexico., González-Inostroz D; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Peña-Nava M; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico., Martín-Márquez BT; Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.; Academic Group UDG-CA-703, 'Immunology and Rheumatology', University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico. |
| المصدر: | Journal of clinical medicine [J Clin Med] 2024 Mar 29; Vol. 13 (7). Date of Electronic Publication: 2024 Mar 29. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2012]- |
| مستخلص: | Metabolic syndrome (MetS) is a group of physiological abnormalities characterized by obesity, insulin resistance (IR), and hypertriglyceridemia, which carry the risk of developing cardiovascular disease (CVD) and type 2 diabetes (T2D). Immune and metabolic alterations have been observed in MetS and are associated with autoimmune development. Systemic lupus erythematosus (SLE) is an autoimmune disease caused by a complex interaction of environmental, hormonal, and genetic factors and hyperactivation of immune cells. Patients with SLE have a high prevalence of MetS, in which elevated CVD is observed. Among the efforts of multidisciplinary healthcare teams to make an early diagnosis, a wide variety of factors have been considered and associated with the generation of biomarkers. This review aimed to elucidate some primary biomarkers and propose a set of assessments to improve the projection of the diagnosis and evolution of patients. These biomarkers include metabolic profiles, cytokines, cardiovascular tests, and microRNAs (miRs), which have been observed to be dysregulated in these patients and associated with outcomes. |
| References: | Sci Rep. 2022 Jun 17;12(1):10175. (PMID: 35715525) Acta Med Okayama. 2022 Aug;76(4):359-371. (PMID: 36123150) Front Immunol. 2022 Oct 19;13:1015882. (PMID: 36341378) Front Physiol. 2021 May 04;12:667330. (PMID: 34017266) Front Immunol. 2022 Jun 09;13:908749. (PMID: 35757707) BMJ Open. 2021 Mar 24;11(3):e038671. (PMID: 33762227) J Transl Autoimmun. 2022 Jan 11;5:100143. (PMID: 35072035) Mediterr J Rheumatol. 2020 Jun 15;31(2):172-173. (PMID: 32676553) Int J Obes (Lond). 2016 Jan;40(1):88-101. (PMID: 26311337) Lupus. 2018 Apr;27(4):564-571. (PMID: 28927316) J Transl Autoimmun. 2022 Dec 22;6:100181. (PMID: 36619655) J Diabetes Metab Disord. 2022 Jan 17;21(1):263-273. (PMID: 35673447) Mediators Inflamm. 2018 Feb 18;2018:3424136. (PMID: 29670462) Cytokine. 2018 Nov;111:20-27. (PMID: 30098476) Biomolecules. 2023 Nov 23;13(12):. (PMID: 38136564) Diabetol Metab Syndr. 2019 Nov 27;11:95. (PMID: 31788032) Curr Treatm Opt Rheumatol. 2017 Sep;3(3):164-172. (PMID: 28840094) Curr Opin Rheumatol. 2018 Sep;30(5):441-448. (PMID: 29870498) Cureus. 2022 Jul 11;14(7):e26751. (PMID: 35967162) Acta Cardiol Sin. 2021 Sep;37(5):464-472. (PMID: 34584379) Ther Adv Musculoskelet Dis. 2022 Feb 14;14:1759720X211073001. (PMID: 35186126) Sci Rep. 2017 Aug 4;7(1):7320. (PMID: 28779080) Angiology. 2018 Mar;69(3):228-235. (PMID: 28635303) Front Immunol. 2021 Aug 02;12:699684. (PMID: 34408748) Ann Rheum Dis. 2022 Jun;81(6):768-779. (PMID: 35110331) Rheumatology (Oxford). 2021 Feb 1;60(2):940-946. (PMID: 32944772) J Multidiscip Healthc. 2022 Dec 28;15:2979-2990. (PMID: 36597468) J Transl Med. 2023 Dec 11;21(1):906. (PMID: 38082368) Lipids Health Dis. 2022 Jan 7;21(1):7. (PMID: 34996484) Front Immunol. 2021 Sep 21;12:726820. (PMID: 34621272) Med Clin (Barc). 2024 Mar 22;162(6):259-264. (PMID: 38040571) Arch Physiol Biochem. 2023 Oct;129(5):1009-1011. (PMID: 33843397) Front Immunol. 2022 Dec 02;13:1059887. (PMID: 36532020) Arthritis Rheum. 2001 Oct;44(10):2331-7. (PMID: 11665973) Clin Chim Acta. 2021 Sep;520:8-15. (PMID: 34022243) Arthritis Rheumatol. 2020 Jan;72(1):20-30. (PMID: 31350818) Lupus Sci Med. 2020 Nov;7(1):. (PMID: 33188034) Horm Metab Res. 2023 Sep;55(9):610-616. (PMID: 36894154) Rheumatol Int. 2023 Aug;43(8):1381-1393. (PMID: 37226016) Molecules. 2022 Jan 06;27(2):. (PMID: 35056647) Obes Facts. 2023;16(6):598-605. (PMID: 37827145) Int J Environ Res Public Health. 2022 Nov 10;19(22):. (PMID: 36429489) Noncoding RNA. 2017 Jun 26;3(3):. (PMID: 29657293) Clin Chim Acta. 2021 Jun;517:41-47. (PMID: 33631197) Curr Obes Rep. 2020 Sep;9(3):245-254. (PMID: 32632847) J Clin Med. 2020 Jan 07;9(1):. (PMID: 31936082) Can J Diabetes. 2022 Jun;46(4):369-374. (PMID: 35484052) Nat Rev Cardiol. 2019 Feb;16(2):83-99. (PMID: 30287946) Nat Metab. 2021 Oct;3(10):1302-1312. (PMID: 34650277) Cells. 2022 Dec 14;11(24):. (PMID: 36552805) J Clin Med. 2019 Jun 05;8(6):. (PMID: 31195632) Medicine (Baltimore). 1992 Sep;71(5):291-302. (PMID: 1522805) J Autoimmun. 2022 Oct;132:102861. (PMID: 35872103) Nutrients. 2023 Jun 14;15(12):. (PMID: 37375654) Curr Atheroscler Rep. 2023 Nov;25(11):819-827. (PMID: 37768411) J Rheumatol. 2006 Jan;33(1):50-6. (PMID: 16395749) Sci Rep. 2023 Nov 2;13(1):18908. (PMID: 37919315) Cytokine. 2016 Oct;86:15-20. (PMID: 27442006) World J Clin Cases. 2022 Oct 26;10(30):10840-10851. (PMID: 36338223) Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231154988. (PMID: 36718110) Endocrinology. 2022 Jul 1;163(7):. (PMID: 35560001) Front Med (Lausanne). 2022 Apr 08;9:849086. (PMID: 35462989) Clin Exp Rheumatol. 2024 Jan;42(1):15-23. (PMID: 34874826) Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231154998. (PMID: 36740569) Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225. (PMID: 28639538) Clinics (Sao Paulo). 2020;75:e1528. (PMID: 32876110) Am J Epidemiol. 2012 Oct 15;176(8):708-19. (PMID: 23024137) World J Diabetes. 2023 Mar 15;14(3):209-221. (PMID: 37035229) Med Princ Pract. 2020;29(6):501-513. (PMID: 32422632) Ann Rheum Dis. 2023 Aug;82(8):999-1014. (PMID: 36792346) Clinics (Sao Paulo). 2020 Oct 19;75:e1801. (PMID: 33084768) Int J Mol Sci. 2021 Oct 04;22(19):. (PMID: 34639078) Front Immunol. 2022 Dec 16;13:1118180. (PMID: 36591294) Cells. 2021 Jan 22;10(2):. (PMID: 33499006) Eur J Prev Cardiol. 2022 Feb 9;28(18):2018-2020. (PMID: 33677495) Nutrients. 2022 Apr 21;14(9):. (PMID: 35565686) Clin Biochem. 2022 Sep;107:55-61. (PMID: 35598633) Antibodies (Basel). 2016 Jan 04;5(1):. (PMID: 31557984) FASEB J. 2021 Mar;35(3):e21391. (PMID: 33565155) Endocr Metab Immune Disord Drug Targets. 2023;23(4):503-514. (PMID: 36089781) Pharmacol Res. 2018 Jul;133:277-288. (PMID: 29382608) J Autoimmun. 2022 Apr;128:102813. (PMID: 35247655) Signal Transduct Target Ther. 2022 Jul 6;7(1):216. (PMID: 35794109) Lupus Sci Med. 2021 Jul;8(1):. (PMID: 34290127) Clin Rheumatol. 2021 Oct;40(10):4253-4258. (PMID: 33839992) Biomedicines. 2021 Nov 05;9(11):. (PMID: 34829857) Autoimmun Rev. 2020 Apr;19(4):102488. (PMID: 32062026) Immunol Res. 2017 Apr;65(2):543-550. (PMID: 28168401) Arch Physiol Biochem. 2022 Dec;128(6):1461-1466. (PMID: 32536220) Cureus. 2022 Oct 15;14(10):e30330. (PMID: 36407159) EBioMedicine. 2023 Oct;96:104802. (PMID: 37725854) Nutrients. 2022 Jan 20;14(3):. (PMID: 35276815) Int J Mol Med. 2022 Apr;49(4):. (PMID: 35137914) Saudi J Kidney Dis Transpl. 2022 Mar-Apr;33(2):272-279. (PMID: 37417179) Lupus. 2020 Aug;29(9):1078-1084. (PMID: 32605528) Clin Sci (Lond). 2021 Mar 26;135(6):731-752. (PMID: 33729498) Heliyon. 2023 Dec 02;10(1):e23114. (PMID: 38163110) Clin Rheumatol. 2023 Jun;42(6):1565-1572. (PMID: 36790644) Int J Mol Sci. 2023 Sep 22;24(19):. (PMID: 37833861) Int J Clin Exp Pathol. 2019 May 01;12(5):1578-1588. (PMID: 31933975) |
| فهرسة مساهمة: | Keywords: CVD; MetS; SLE; adipokines; microRNA |
| تواريخ الأحداث: | Date Created: 20240413 Latest Revision: 20240425 |
| رمز التحديث: | 20240425 |
| مُعرف محوري في PubMed: | PMC11012563 |
| DOI: | 10.3390/jcm13071988 |
| PMID: | 38610754 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2077-0383 |
|---|---|
| DOI: | 10.3390/jcm13071988 |